Status:
COMPLETED
Integration of Yoga for the Treatment of Obesity in Adults
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institutes of Health (NIH)
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Obesity
Physical Activity
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The focus of this study is to examine the feasibility of integrating Vinyasa yoga into a Standard Behavioral Weight Loss Intervention, to examine whether engagement differs between Vinyasa yoga and a ...
Detailed Description
The focus of this study is to examine the feasibility of integrating Vinyasa yoga into a Standard Behavioral Weight Loss Intervention, to examine whether engagement differs between Vinyasa yoga and a ...
Eligibility Criteria
Inclusion
- Both males and females of all race/ethnic groups are eligible for participation in this study.
- 18-60 years of age.
- Body mass index (BMI) between 25.0 to \<40.0 kg/m2.
- Ability to provide informed consent prior to participation in this study.
- Ability to provide clearance from their primary care physician to engage in the diet and physical activity components of the weight loss intervention.
Exclusion
- Report moderate-to-vigorous exercise on \>3 days per week or a total of \>60 minutes per week over the past 3 months.
- Engaging in any style of yoga on an average of at least 1 day per week over the past 3 months.
- Report weight loss of \>3% or participating in a weight reduction diet in the past 3 months.
- Females who are pregnant or breastfeeding, or reporting a planned pregnancy during the study period.
- History of bariatric surgery.
- Report current medical condition or treatment for a medical condition that could affect body weight. These may include the following: diabetes mellitus; hyperthyroidism; inadequately controlled hypothyroidism; chronic renal insufficiency; chronic liver disease; cancer; gastrointestinal disorders including ulcerative colitis, Crohn's disease, or malabsorption syndromes; etc.
- Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e. recent or recurrent DVT).
- Resting systolic blood pressure of \>160 mmHg or resting diastolic blood pressure of \>100 mmHg.
- Eating disorders that would contraindicate weight loss or physical activity.
- Alcohol or substance abuse.
- Currently treated for psychological issues (i.e., depression, bipolar disorder, etc.), taking psychotropic medications within the previous 12 months, or hospitalized for depression within the previous 5 years.
- Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance at scheduled intervention sessions or assessments.
- Physical activity or weight loss deemed to be contraindicated based on response to the cardiorespiratory fitness test that will be conducted as part of the screening procedures.
Key Trial Info
Start Date :
April 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03459937
Start Date
April 25 2018
End Date
December 31 2018
Last Update
November 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15260